Carcinoid Cancer Foundation

Biochemical Assessment of Niacin Deficiency Among Carcinoid Cancer Patients

Girish M. Shah, Rashmi G. Shah, Hélène Veillette et al. · The American Journal of Gastroenterology · 2005 · 106 citations

Medicine, Biochemistry, Oncology +14

Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors

Edward M. Wolin, John Leyden, Grace Goldstein et al. · Pancreas · 2017 · 59 citations · Full text

Medicine, Endocrinology, Oncology +17

Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals

Simone Leyden, Teodora Kolarova, Catherine Bouvier et al. · International Journal of Cancer · 2019 · 32 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

Pivotal phase III COMPOSE trial will compare ¹⁷⁷Lu-edotreotide with best standard of care for well-differentiated aggressive grade 2 and grade 3 gastroenteropancreatic neuroendocrine tumors.

Diane Reidy‐Lagunes, Namrata Vijayvergia, Daniel M. Halperin et al. · Journal of Clinical Oncology · 2022 · 24 citations

Medicine, Nuclear Medicine, Pharmacology +13

PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly

Dermot O’Toole, Pamela L. Kunz, Susan M. Webb et al. · Advances in Therapy · 2022 · 15 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +8